Chugai reported 45% growth in overseas sales in 3Q24, driven by Hemlibra. The company raised 2024 guidance, which calls for revenue and core operating profit growth of 3% and 20%, YoY, respectively.
What is covered in the Full Insight:
Financial Performance Overview
Upward Revision of 2024 Guidance
Hemlibra's Market Momentum
Challenges in Domestic Market
Outlook and Valuation
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.